7Baggers
 Q4 EPS Forecast for Tenax Therapeutics Raised by Analyst  Defense World Mon, 17 Nov 2025 08:38:47 GMT
 This analyst loves Tenax Therapeutics  Cantech Letter Sun, 16 Nov 2025 16:04:44 GMT
 How sentiment analysis helps forecast Tenax Therapeutics Inc.  newser.com Thu, 13 Nov 2025 23:55:38 GMT
 Tenax Therapeutics: Q3 Earnings Snapshot  CTPost Thu, 13 Nov 2025 04:57:08 GMT
 Tenax Therapeutics (TENX) Advances Key Program for PH-HFpEF Trea  GuruFocus Wed, 12 Nov 2025 23:17:06 GMT
 Tenax Therapeutics reports Q3 EPS (40c), consensus ($1.12)  TipRanks Wed, 12 Nov 2025 22:41:16 GMT
 Tenax Therapeutics: Q3 Earnings Snapshot  San Francisco Chronicle Wed, 12 Nov 2025 22:17:10 GMT
 Tenax Therapeutics Q3 net loss widens  MarketScreener Wed, 12 Nov 2025 21:31:31 GMT
 How (TENX) Movements Inform Risk Allocation Models  news.stocktradersdaily.com Wed, 12 Nov 2025 13:14:02 GMT

Tenax Therapeutics, Inc
(NASDAQ:TENX) 

TENX stock logo

Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. The company develops levosimendan, which completed a phase II clinical trials for the treatment of...

Founded: 1967
Full Time Employees: 9
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends